300
Participants
Start Date
April 30, 2013
Primary Completion Date
October 31, 2015
Study Completion Date
October 31, 2015
Liraglutide
Active Drug
Placebo
Placebo
Lancaster Heart and Stroke Foundation, Lancaster
University of Pennsylvaina, Philadelphia
Jefferson Medical College, Philadelphia
Temple University Hospital, Philadelphia
Christiana Care Health Services, Newark
Johns Hopkins Hospital, Baltimore
Duke University, Durham
Southeast Regional Medical Center, Lumberton
Emory University School of Medicine, Atlanta
University Hospitals- Case Medical Center, Cleveland
Metro Health System, Cleveland
Cleveland Clinic, Cleveland
Mayo Clinic, Rochester
Northwestern University, Chicago
Washington University, St Louis
Saint Louis University Hospital, St Louis
Michael Debakey VA Medical Center, Houston
University of Utah School of Medicine, Salt Lake City
Utah VA Medical Center, Salt Lake City
Intermountain Medical Center, Murray
Tufts Medical Center, Boston
Massachusetts General Hospital, Boston
Brigham and Women's Hospital, Boston
Boston VA Healtcare System, West Roxbury
The University of Vermont- Fletcher Allen Health Care, Burlington
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Duke University
OTHER